4//SEC Filing
Gleeson Michael 4
Accession 0001487371-21-000148
CIK 0001487371other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 4:38 PM ET
Size
14.2 KB
Accession
0001487371-21-000148
Insider Transaction Report
Form 4
Gleeson Michael
SVP, Sales
Transactions
- Exercise/Conversion
Common Stock
2021-04-14$13.17/sh+4,926$64,875→ 407,623 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-04-14$10.89/sh−12,787$139,250→ 12,001 totalExercise: $10.89From: 2017-03-06Exp: 2023-03-06→ Common Stock (12,787 underlying) - Exercise/Conversion
Common Stock
2021-04-14$12.30/sh+9,954$122,434→ 402,697 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-04-14$12.30/sh−9,954$122,434→ 5,118 totalExercise: $12.30From: 2018-03-06Exp: 2024-03-06→ Common Stock (9,954 underlying) - Exercise/Conversion
Common Stock
2021-04-14$10.89/sh+12,787$139,250→ 420,410 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-04-14$13.17/sh−4,926$64,875→ 989 totalExercise: $13.17From: 2019-02-19Exp: 2025-02-19→ Common Stock (4,926 underlying)
Holdings
- 30,069(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Mr. Gleeson is the trustee of the Michael William Gleeson 2012 Irrevocable Trust and has voting and dispositive power with respect to these shares. Mr. Gleeson disclaims beneficial ownership except to the extent of his pecuniary interest therein.
Documents
Issuer
GenMark Diagnostics, Inc.
CIK 0001487371
Entity typeother
Related Parties
1- filerCIK 0001543884
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 4:38 PM ET
- Size
- 14.2 KB